Published in J Gen Intern Med on May 15, 2007
Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review. Int J Equity Health (2010) 0.91
Medicare part d and the federal employees health benefits program: a comparison of prescription drug coverage. Am Health Drug Benefits (2013) 0.75
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med (2004) 6.21
Unintended consequences of caps on Medicare drug benefits. N Engl J Med (2006) 5.67
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) (2006) 3.16
Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA (2004) 2.66
Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) (2003) 2.37
Angiotensin II antagonists for hypertension: are there differences in efficacy? Am J Hypertens (2000) 2.35
Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med (2005) 1.98
The first months of the prescription-drug benefit--a CMS update. N Engl J Med (2006) 1.32
The new medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med (2005) 1.22
Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther (1996) 1.01
A first look at the new Medicare prescription drug plans. Health Aff (Millwood) (2006) 0.95
Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials. Curr Opin Cardiol (2006) 0.82
ACE inhibitor intolerance and lessons learned from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) trials. Congest Heart Fail (2004) 0.79
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med (2006) 3.90
Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70
Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med (2005) 3.55
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
Body mass index, provider advice, and target gestational weight gain. Obstet Gynecol (2005) 2.38
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med (2010) 2.24
Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med (2004) 2.21
Association between language proficiency and the quality of primary care among a national sample of insured Latinos. Med Care (2007) 2.21
Moving beyond parity--mental health and addiction care under the ACA. N Engl J Med (2011) 2.20
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf (2010) 2.03
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
New Jersey's efforts to improve postpartum depression care did not change treatment patterns for women on medicaid. Health Aff (Millwood) (2011) 1.83
Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc (2005) 1.82
Medicare Part D and nursing home residents. J Am Geriatr Soc (2007) 1.74
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
A political history of federal mental health and addiction insurance parity. Milbank Q (2010) 1.70
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Elucidating the role of place in health care disparities: the example of racial/ethnic residential segregation. Health Serv Res (2012) 1.55
The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health (2003) 1.53
Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder. J Clin Psychiatry (2012) 1.48
Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr Serv (2003) 1.39
Prescription drug dispensing limits and patterns. Manag Care Interface (2005) 1.38
Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. JAMA (2011) 1.36
Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother (2009) 1.36
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35
Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res (2012) 1.35
The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry (2013) 1.34
Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics (2007) 1.33
Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry (2010) 1.32
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
The effect of area HMO market share on cancer screening. Health Serv Res (2004) 1.29
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care (2002) 1.26
An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med (2009) 1.26
Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. PLoS Med (2011) 1.26
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21
Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders. J Womens Health (Larchmt) (2005) 1.16
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr (2012) 1.15
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
Factors affecting breast cancer risk reduction practices among California physicians. Prev Med (2004) 1.14
An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ (2003) 1.14
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract (2010) 1.14
Dual eligibles with mental disorders and Medicare part D: how are they faring? Health Aff (Millwood) (2009) 1.11
Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract (2011) 1.10
Predictors of compliance with the postpartum visit among women living in healthy start project areas. Matern Child Health J (2006) 1.09
The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation. Med Care (2006) 1.09
Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) (2005) 1.07
Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med (2011) 1.07
Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception (2010) 1.06
Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med (2013) 1.05
Case-mix adjustment of consumer reports about managed behavioral health care and health plans. Health Serv Res (2008) 1.05
Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer (2011) 1.04
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res (2008) 1.00
Differences in hospice care between home and institutional settings. J Palliat Med (2007) 0.99
Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care. J Gen Intern Med (2013) 0.98
Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder. Med Care (2009) 0.98
Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med (2014) 0.98
What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings. J Gen Intern Med (2008) 0.98
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care (2004) 0.97
Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. J Gen Intern Med (2011) 0.97
Factors affecting participation in a breast cancer risk reduction telephone survey among women from four racial/ethnic groups. Prev Med (2005) 0.96
Use of practice-based research network data to measure neighborhood smoking prevalence. Prev Chronic Dis (2013) 0.96
Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatr Serv (2013) 0.95
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw (2011) 0.95
Disparities in cancer screening in individuals with a family history of breast or colorectal cancer. Cancer (2011) 0.95
Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs. Health Serv Res (2008) 0.95
Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood) (2006) 0.94
Race/ethnicity, socioeconomic status and the health of pregnant women. J Health Psychol (2007) 0.93
Medicare part D and the nursing home setting. Gerontologist (2008) 0.93
Influence of body weight on patients' satisfaction with ambulatory care. J Gen Intern Med (2002) 0.93
Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med (2010) 0.92
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat (2012) 0.92
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Patient costs for medication abortion: results from a study of five clinical practices. Womens Health Issues (2006) 0.91
Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care (2003) 0.90
The influence of Medicare home health payment incentives: does payer source matter? Inquiry (2006) 0.90
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90
Association of breastfeeding with maternal depressive symptoms. J Womens Health (Larchmt) (2006) 0.89